CBGL stock down to $0.000001 on 22 Jan 2026: PNK-listed plunge and what to watch
CBGL stock plunged to $0.000001 on 22 Jan 2026 during regular market hours on the PNK exchange in the United States. The move marks a -99.00% one-day change from the prior close of $0.000100 and follows thin trading with 710,198 shares changing hands versus a 50-day average of 11,917,533 shares. Cannabis Global, Inc. (CBGL) now carries a market cap of approximately $28,410.00 and a tiny cash-per-share base. We use Meyka AI’s data and model-driven tools to explain the drop, valuation metrics, and a forecast-backed view for traders and risk managers.
Market snapshot for CBGL stock
Cannabis Global, Inc. (CBGL) trades on the PNK exchange in the United States and opened today at $0.000100. The intraday range was $0.000001 to $0.000100 with a reported volume of 710,198 shares. Year-to-date and longer-term averages show very low absolute prices: 50-day average $0.000103 and 200-day average $0.000092. The combination of micro-price, tiny market cap of $28,410.00, and low liquidity explains why price moves are extreme on small flows.
Why CBGL stock moved: immediate drivers
The immediate driver was heavy selling into a very small float and thin bid depth, not a public earnings update or scheduled announcement. Cannabis Global has reported negative EPS of -0.01 and no recent earnings release, which keeps investor confidence fragile. With only three full-time employees reported and operating cash thin, any sell pressure quickly erodes the quote. Market participants often treat sub-penny PNK names as headline-driven and liquidity-driven, increasing volatility risk.
CBGL stock financials, ratios and valuation
Key posted metrics show weak fundamentals: book value per share -0.000928, current ratio 0.05, and enterprise value reported near $3,915,783.00, which signals a distorted EV relative to market cap. Price-to-earnings is not meaningful (PE: None) because trailing EPS is negative. Operating cash flow per share and revenue per share are essentially zero, indicating limited operating scale. Sector classification is Healthcare and industry is Drug Manufacturers – Specialty & Generic, where peers trade at materially higher multiples and larger liquidity.
Meyka Grade and model valuation for CBGL stock
Meyka AI rates CBGL with a score out of 100: 64.97 (Grade: B) with a suggestion to HOLD. This grade factors in S&P 500 and sector comparisons, financial growth, key metrics, forecasts, and analyst signals. Meyka AI’s forecast model projects a 1-year price of $0.001105 versus the current $0.000001, implying very large model upside but with extreme uncertainty. These grades are not guaranteed and we are not financial advisors.
Technicals, liquidity and trading risk for CBGL stock
Technical indicators are unreliable at sub-penny scales, but reported RSI near 51.87 and ADX 30.37 point to a trend presence amid volatile prices. Average volume (50-day) is 11,917,533, far above today’s 710,198, which signals inconsistent liquidity spikes. Bid-ask gaps and potential market maker withdrawal can cause rapid price gaps. Investors should expect outsized slippage and low short-term tradability.
Outlook, price targets and scenario planning for CBGL stock
Meyka scenario math produces a conservative range: a downside continued-pressure case to $0.000000 or technical delisting risk, a base recovery scenario near $0.000500, and an optimistic model target around $0.001105 in 12 months if operations and liquidity improve. Given current shares outstanding of 568,209,000 and market cap $28,410.00, realistic upside requires material revenue or corporate action. Use tight position sizing and treat CBGL as high-risk speculative exposure.
Final Thoughts
CBGL stock traded to $0.000001 on 22 Jan 2026, driven by thin liquidity and negative fundamentals rather than a public earnings surprise. Cannabis Global, Inc. shows negative EPS (-0.01), a shallow cash buffer, and a distorted enterprise value, which keeps valuation signals weak. Meyka AI rates CBGL 64.97/100 (B, HOLD) and models a 12-month forecast of $0.001105, implying a theoretical upside of roughly 110,397.75% from today’s quote, though this is model-driven and improbable without major operational change. For traders the priority is liquidity management and tight risk controls; for investors the key is to watch any corporate disclosures, cash injections, or meaningful sales updates before increasing exposure. Forecasts are model-based projections and not guarantees.
FAQs
What caused the sharp fall in CBGL stock today?
The fall reflects extreme illiquidity and selling pressure in a sub-penny PNK listing rather than a public earnings release; CBGL has low cash per share and negative EPS, which increases downside sensitivity.
What is Meyka AI’s short-term forecast for CBGL stock?
Meyka AI’s forecast model projects about $0.001105 in 12 months, but the projection is model-based and not a guarantee given the stock’s liquidity and operational constraints.
Is CBGL stock a buy after the drop?
Given Cannabis Global’s tiny market cap, weak ratios and low liquidity, Meyka’s grade suggests HOLD; only highly risk-tolerant investors with strict position limits should consider buying.
Where can I find the latest CBGL stock news and filings?
For the latest coverage see industry news feeds and the listed recent market mention [Markets Insider coverage](https://markets.businessinsider.com/searchresults?p=2&_search=%E9%95%BF%E6%98%A5%E5%8D%97%E5%85%B3%E5%8C%BA%E6%89%BE%E5%B0%8F%E5%A7%90%E4%B8%8A%E9%97%A8%E6%9C%8D%E5%8A%A1%E9%A2%84%E7%BA%A6
Disclaimer:
Stock markets involve risks. This content is for informational purposes only. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.
